The influences of hyperprolactinemia and obesity on cardiovascular risk markers: Effects of cabergoline therapy

Clinical Endocrinology

Volumn 64, Issue 4, 2006, Pages 366-370

  Serri, Omar ^a   Li, Ling ^a   Mamputu, Jean Claude ^a   Beauchamp, Marie Claude ^a   Maingrette, Fritz ^a   Renier, Geneviève ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CABERGOLINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CARDIOVASCULAR RISK; CELL ACTIVATION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERPROLACTINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MONONUCLEAR CELL; OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; E-SELECTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERGOLINES; FEMALE; HUMANS; HYPERPROLACTINEMIA; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; LINEAR MODELS; LIPIDS; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33644922349     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02469.x     Document Type: Article

References (24)

1. Josimovich J.B. Lavenhar M.A. Devanesan M.M. Sesta H.J. Wilchins S.A. Smith A.C. 1987 Heterogeneous distribution of serum prolactin values in apparently healthy young women, and the effects of oral contraceptive medication Fertility and Sterility 47 785 791
2. Serri O. Beauregard H. Rasio E. Hardy J. 1986 Decreased sensitivity to insulin in women with microprolactinomas Fertility and Sterility 45 572 574
3. Gustafson A.B. Banasiak M.F. Kalkhoff R.K. Hagen T.C. Kim H.J. 1980 Correlation of hyperprolactinemia with altered plasma insulin and glucagon: similarity to effects of late human pregnancy Journal of Clinical Endocrinology and Metabolism 51 242 246
4. Schernthaner G. Prager R. Punzengruber C. Luger A. 1985 Severe hyperprolactinemia is associated with decreased insulin binding in vitro and insulin resistance in vivo Diabetologia 28 138 142
5. Greenman Y. Tordjman K. Stern N. 1998 Increased body weight associated with prolactin-secreting pituitary adenomas: weight loss with normalization of prolactin levels Clinical Endocrinology 48 547 553
6. Yavuz D. Deyneli O. Akpinar I. Yildiz E. Gözü H. Sezgin O. Haklar G. Akalin S. 2003 Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women European Journal of Endocrinology 149 187 193
7. Ross R. 1999 Atherosclerosis is an inflammatory disease New England Journal of Medicine 340 115 126
8. Yu-Lee L.Y. 2002 Prolactin modulation of immune and inflammatory responses Recent Progress in Hormone Research 57 435 455
9. Matthews D.R. Hosker J.P. Rudenski A.S. Naylor B.A. Treacher D.F. Turner R.C. 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412 419
10. Han J.H. Beutler B. Huez G. 1991 Complex regulation of tumor necrosis factor mRNA turnover in lipopolysaccharide-activated macrophages Biochimica et Biophysica Acta 1090 22 28
11. Bradford M.M. 1976 A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding Analytical Biochemistry 72 248 254
12. Ridker P.M. Cushman M. Stampfer M.J. Tracy R.P. Hennekens C.H. 1997 Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men New England Journal of Medicine 336 973 979
13. Pearson T.A. Mensah G.A. Alexander R.W. Anderson J.L. Cannon R.O. Criqui M Fadl Y.Y. Fortmann S.P. Hong Y. Myers G.L. Rifai N. Smith S.C. Jr. Taubert K. Tracy R.P. Vinicor F. 2003 Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for health care professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 499 511
14. Toniatti C. Arcone R. Majello B. Ganter U. Arpaia G. Ciliberto G. 1990 Regulation of the human C-reactive protein gene, a major marker of inflammation and cancer Molecular and Biological Medicine 7 199 212
15. Ganapathi M.K. Rzewnicki D. Samols D. Jiang S.L. Kushner I. 1991 Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells Journal of Immunology 147 1261 1265
16. Hotamisligil G.S. 1999 The role of TNFα and TNF receptors in obesity and insulin resistance Journal of Internal Medicine 245 621 625
17. Pober J.S. 2002 Endothelial activation: intracellular signaling pathways Arthritis Research 4 S109 S116
18. Serri O. St-Jacques P. Sartippour M. Renier G. 1999 Alterations of monocyte function in patients with growth hormone (GH) deficiency; effect of substitutive GH therapy Journal of Clinical Endocrinology and Metabolism 84 58 63
19. Collins T. 1993 Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion Laboratory Investigations 68 499 508
20. Dandona P. Aljada A. Bandyopadhyay A. 2004 Inflammation: the link between insulin resistance, obesity and diabetes Trends in Immunology 25 4 7
21. Festa A. D'Agostino R. Jr. Howard G. Mykkanen L. Tracy R.P. Haffner S.M. 2000 Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS) Circulation 102 42 47
22. Yudkin J.S. Stehouwer C.D. Emeis J.J. Coppack S.W. 1999 C-reactive protein in healthy subjects; association with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue? Arteriosclerosis, Thrombosis and Vascular Biology 19 972 978
23. Marsden P.J. Murdoch A.P. Taylor R. 2000 Adipocyte insulin action in hypogonadotrophic hypogonadism Human Reproduction 15 1672 1678
24. Korner J. Lo J. Freda P.U. Wardlaw S.L. 2003 Treatment with cabergoline is associated with weight loss in patients with hyperprolactinemia Obesity Research 11 311 312